Authors





Tzu-En Wu, MD

Latest:

Long-term Glycemic Control After 6 Months of Basal Insulin Therapy

The authors evaluate long-term glycemic control in a 5-year follow-up period after patients with newly diagnosed type 2 diabetes mellitus with severe hyperglycemia were treated with 6 months of basal insulin therapy in a randomized controlled trial.


Sean M. Studer, MD, MSc

Latest:

Considerations for Optimal Management of Patients With Pulmonary Arterial Hypertension: A Multi-Stakeholder Roundtable Discussion

Stakeholders, including national and regional managed care decision makers and providers, met to discuss the clinical background, health economics, and management strategies for pulmonary arterial hypertension (PAH) at a roundtable meeting on December 10, 2016, in Dallas, Texas.





Laura Skopec, MS

Latest:

Did Medicare Advantage Payment Cuts Affect Beneficiary Access and Affordability?

The Affordable Care Act’s reductions to Medicare Advantage plan payments were not significantly associated with healthcare access or affordability for enrollees.




Louis J. DeGennaro, PhD

Latest:

Solutions for Reducing Patient Cost Sharing for Medications

Cost sharing for medications presents a serious access barrier for many blood cancer patients. Available solutions, if embraced by policymakers, could reduce such cost sharing with very little impact on premiums.






Hui-Ru Chang, PhD

Latest:

Can Cancer Patients Seeking a Second Opinion Get Better Care?

Colorectal resection patients in Taiwan with heavy hospital shopping behaviors got better surgical care than those who did not shop or hospitals.


Karen E. Joynt, MD, MPH

Latest:

Concentration of High-Cost Patients in Hospitals and Markets

High-cost patients are only modestly concentrated in specific hospitals and healthcare markets.



Adrianne C. Feldstein, MD, MS

Latest:

More Comprehensive Discussion of CRC Screening Associated With Higher Screening

More comprehensive discussion of colorectal screening by primary care physicians was associated with higher screening rates among adults aged 51 to 80 years who were overdue for screening.


Kevin Bowman, MD

Latest:

Leveraging Benefit Design for Better Diabetes Self-Management and A1C Control

Patients with diabetes receiving insulin treatment with lower cost sharing for blood glucose testing strips were more likely to achieve glycemic control than those with higher cost sharing.


Sujoy Chakravarty, PhD

Latest:

Hospital Responses to DSRIP Program Reforms in New Jersey

This study examines the New Jersey Delivery System Reform Incentive Payment (DSRIP) program using hospital web surveys and key informant interviews and finds progress toward data-driven population health management for low-income patients.


David M. Sloan, PhD

Latest:

Improving Quality Measure Maintenance: Navigating the Complexities of Evolving Evidence

An exploration of potential negative effects from delays in measure maintenance when changes in clinical evidence affect measure use found that delays may affect patient care and outcomes.


Jaclyn Rappaport, MPP, MBA

Latest:

Enhancing Patient and Family Engagement Through Meaningful Use Stage 3: Opportunities and Barriers to Implementation

Two leading US health systems attempted to implement 4 draft objectives for Meaningful Use Stage 3 within their health IT infrastructure to provide feedback on needed enhancements to the policy.



Shaoang Zhang, PhD

Latest:

Clinical and Economic Outcomes Associated With Potentially Inappropriate Prescribing in the Elderly

Clinical and economic outcomes associated with the use of specific potentially inappropriate medications in the elderly were evaluated.



Karisa K. Harland, PhD, MPH

Latest:

Against the Current: Back-Transfer as a Mechanism for Rural Regionalization

The authors investigated back-transfer: the transfer of patients near the end of an acute hospitalization to a local community hospital for completion of their medical care.


Bruce Wolfe, MD

Latest:

Cost-Effectiveness Analysis of Vagal Nerve Blocking for Morbid Obesity

This lifetime economic analysis demonstrates vagal nerve blocking therapy to be a cost-effective alternative to conventional therapy in class 2 and 3 obesity patients.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo